ciprofloxacin has been researched along with Rhabdomyolysis in 6 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rhabdomyolysis is one of the serious side effects of ciprofloxacin (CPFX), a widely used antibacterial drug; and occasionally, acute kidney injury (AKI) occurs." | 7.88 | Establishment of a drug-induced rhabdomyolysis mouse model by co-administration of ciprofloxacin and atorvastatin. ( Akai, S; Matsubara, A; Oda, S; Tsuneyama, K; Yokoi, T, 2018) |
| " In this patient, however, the clinical course was dramatically complicated by the development of ciprofloxacin-associated rhabdomyolysis." | 7.79 | Ventilator-associated pneumonia caused by OXA-48-producing Escherichia coli complicated by ciprofloxacin-associated rhabdomyolysis. ( Fruhwald, S; Grisold, AJ; Hoenigl, M; Ovcina, I; Valentin, T, 2013) |
| "As ciprofloxacin is a weak inhibitor of CYP3A4, it is very likely that other mechanisms involving the ATP-binding cassette drug efflux transporter family played a role in this drug interaction." | 5.35 | Rhabdomyolysis due to an uncommon interaction of ciprofloxacin with simvastatin. ( Sawant, RD, 2009) |
| "Rhabdomyolysis is one of the serious side effects of ciprofloxacin (CPFX), a widely used antibacterial drug; and occasionally, acute kidney injury (AKI) occurs." | 3.88 | Establishment of a drug-induced rhabdomyolysis mouse model by co-administration of ciprofloxacin and atorvastatin. ( Akai, S; Matsubara, A; Oda, S; Tsuneyama, K; Yokoi, T, 2018) |
| " In this patient, however, the clinical course was dramatically complicated by the development of ciprofloxacin-associated rhabdomyolysis." | 3.79 | Ventilator-associated pneumonia caused by OXA-48-producing Escherichia coli complicated by ciprofloxacin-associated rhabdomyolysis. ( Fruhwald, S; Grisold, AJ; Hoenigl, M; Ovcina, I; Valentin, T, 2013) |
| "Rhabdomyolysis and acute renal failure were successfully treated by transfusion, diuretic therapy, and glucocorticoid therapy." | 1.32 | [Surviving case of Legionella pneumonia showing a high level of serum KL-6 and complicated with rhabdomyolysis]. ( Kawai, A; Nakajima, H; Nakajima, S; Sawaguchi, H; Touda, Y, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsubara, A | 1 |
| Oda, S | 1 |
| Akai, S | 1 |
| Tsuneyama, K | 1 |
| Yokoi, T | 1 |
| Grisold, AJ | 1 |
| Hoenigl, M | 1 |
| Ovcina, I | 1 |
| Valentin, T | 1 |
| Fruhwald, S | 1 |
| Goldie, FC | 1 |
| Brogan, A | 1 |
| Boyle, JG | 1 |
| Shimura, C | 1 |
| Saraya, T | 1 |
| Wada, H | 1 |
| Takata, S | 1 |
| Mikura, S | 1 |
| Yasutake, T | 1 |
| Kato, J | 1 |
| Kato, A | 1 |
| Yamamoto, M | 1 |
| Watanabe, M | 1 |
| Yokoyama, T | 1 |
| Kurai, D | 1 |
| Ishii, H | 1 |
| Aoshima, M | 1 |
| Yamada, A | 1 |
| Goto, H | 1 |
| Sawant, RD | 1 |
| Kawai, A | 1 |
| Nakajima, H | 1 |
| Sawaguchi, H | 1 |
| Touda, Y | 1 |
| Nakajima, S | 1 |
1 review available for ciprofloxacin and Rhabdomyolysis
| Article | Year |
|---|---|
Pathological evidence of rhabdomyolysis-induced acute tubulointerstitial nephritis accompanying Legionella pneumophila pneumonia.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Humans; Kidney; Legionella pneumophila; Legionna | 2008 |
5 other studies available for ciprofloxacin and Rhabdomyolysis
| Article | Year |
|---|---|
Establishment of a drug-induced rhabdomyolysis mouse model by co-administration of ciprofloxacin and atorvastatin.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Atorvastatin; Buth | 2018 |
Ventilator-associated pneumonia caused by OXA-48-producing Escherichia coli complicated by ciprofloxacin-associated rhabdomyolysis.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Escherichia coli; Escherichia coli Infections | 2013 |
Ciprofloxacin and statin interaction: a cautionary tale of rhabdomyolysis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Interactions; Female; Humans; Hydroxymethylglutaryl-CoA R | 2016 |
Rhabdomyolysis due to an uncommon interaction of ciprofloxacin with simvastatin.
Topics: Aged; Anti-Infective Agents; ATP-Binding Cassette Transporters; Ciprofloxacin; Cytochrome P-450 CYP3 | 2009 |
[Surviving case of Legionella pneumonia showing a high level of serum KL-6 and complicated with rhabdomyolysis].
Topics: Acute Kidney Injury; Aged; Anti-Infective Agents; Antibodies, Bacterial; Antigens; Antigens, Bacteri | 2004 |